These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 31120825)

  • 1. Novel Therapies for Prevention and Early Treatment of Cardiomyopathies.
    Repetti GG; Toepfer CN; Seidman JG; Seidman CE
    Circ Res; 2019 May; 124(11):1536-1550. PubMed ID: 31120825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targets for therapy in sarcomeric cardiomyopathies.
    Tardiff JC; Carrier L; Bers DM; Poggesi C; Ferrantini C; Coppini R; Maier LS; Ashrafian H; Huke S; van der Velden J
    Cardiovasc Res; 2015 Apr; 105(4):457-70. PubMed ID: 25634554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disease-Modifying Treatments for Transthyretin Amyloidosis.
    Tushak ZJ; Cox SZ; Cei LF; Gwathmey KG; Shah KB
    J Cardiovasc Pharmacol; 2021 Nov; 78(5):e641-e647. PubMed ID: 34321398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiomyopathies and Genetic Testing in Heart Failure: Role in Defining Phenotype-Targeted Approaches and Management.
    Yogasundaram H; Alhumaid W; Dzwiniel T; Christian S; Oudit GY
    Can J Cardiol; 2021 Apr; 37(4):547-559. PubMed ID: 33493662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic advances in sarcomeric cardiomyopathies: state of the art.
    Ho CY; Charron P; Richard P; Girolami F; Van Spaendonck-Zwarts KY; Pinto Y
    Cardiovasc Res; 2015 Apr; 105(4):397-408. PubMed ID: 25634555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modelling sarcomeric cardiomyopathies in the dish: from human heart samples to iPSC cardiomyocytes.
    Eschenhagen T; Mummery C; Knollmann BC
    Cardiovasc Res; 2015 Apr; 105(4):424-38. PubMed ID: 25618410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiomyopathy.
    Cruickshank S
    Nurs Stand; 2004 Feb 18-24; 18(23):46-52; quiz 54-6. PubMed ID: 15017816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Research priorities in sarcomeric cardiomyopathies.
    van der Velden J; Ho CY; Tardiff JC; Olivotto I; Knollmann BC; Carrier L
    Cardiovasc Res; 2015 Apr; 105(4):449-56. PubMed ID: 25631582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Palmoplantar Keratoderma and Woolly Hair Revealing Asymptomatic Arrhythmogenic Cardiomyopathy.
    Guerra L; Magliozzi M; Baban A; Di Mambro C; Di Zenzo G; Novelli A; El Hachem M; Zambruno G; Castiglia D
    Acta Derm Venereol; 2019 Jul; 99(9):831-832. PubMed ID: 31073624
    [No Abstract]   [Full Text] [Related]  

  • 10. Pericarditis, myocarditis, and other cardiomyopathies.
    Shammas NW; Padaria RF; Coyne EP
    Prim Care; 2013 Mar; 40(1):213-36. PubMed ID: 23402470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical practice guidelines for hereditary cardiomyopathy].
    Writing Group For Practice Guidelines For Diagnosis And Treatment Of Genetic Diseases Medical Genetics Branch Of Chinese Medical Association ; Sun J; Han S; Hu J; Jiang C; Wang Q; Zheng L; Zhou Z; Qi M
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2020 Mar; 37(3):300-307. PubMed ID: 32128748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pediatric Cardiomyopathies.
    Lee TM; Hsu DT; Kantor P; Towbin JA; Ware SM; Colan SD; Chung WK; Jefferies JL; Rossano JW; Castleberry CD; Addonizio LJ; Lal AK; Lamour JM; Miller EM; Thrush PT; Czachor JD; Razoky H; Hill A; Lipshultz SE
    Circ Res; 2017 Sep; 121(7):855-873. PubMed ID: 28912187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tailoring therapy for ischemic cardiomyopathy: is Laplace's law enough?
    Adhyapak SM; Parachuri VR
    Ther Adv Cardiovasc Dis; 2017 Sep; 11(9):231-234. PubMed ID: 28689451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiomyocyte Dysfunction in Inherited Cardiomyopathies.
    Hassoun R; Budde H; Mügge A; Hamdani N
    Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defining phenotypes and disease progression in sarcomeric cardiomyopathies: contemporary role of clinical investigations.
    Olivotto I; d'Amati G; Basso C; Van Rossum A; Patten M; Emdin M; Pinto Y; Tomberli B; Camici PG; Michels M
    Cardiovasc Res; 2015 Apr; 105(4):409-23. PubMed ID: 25631583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic basis and molecular biology of cardiac arrhythmias in cardiomyopathies.
    Marian AJ; Asatryan B; Wehrens XHT
    Cardiovasc Res; 2020 Jul; 116(9):1600-1619. PubMed ID: 32348453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of mutations in the SCN5A gene in cardiomyopathies.
    Zaklyazminskaya E; Dzemeshkevich S
    Biochim Biophys Acta; 2016 Jul; 1863(7 Pt B):1799-805. PubMed ID: 26916278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mind the Gap: Genetic Variation and Personalized Therapies for Cardiomyopathies.
    Zhang Y; MacCosham A
    Lifestyle Genom; 2018; 11(2):77-79. PubMed ID: 30231257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Classification, genetic predisposition and risk factors for the development of cardiomyopathies].
    Pankuweit S; Richter A; Ruppert V; Funck R; Maisch B
    Internist (Berl); 2008 Apr; 49(4):441-2, 444-7. PubMed ID: 18274717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Classification, Epidemiology, and Global Burden of Cardiomyopathies.
    McKenna WJ; Maron BJ; Thiene G
    Circ Res; 2017 Sep; 121(7):722-730. PubMed ID: 28912179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.